BHL-I was capable of binding to human CD3 and human ovarian cancer as detected by ELISA and by FACS analysis of T cells and SKOV3 cells, respectively.

• 另外，BHL-I不仅与T细胞及卵巢癌细胞(SKOV3)具有良好的结合活性，而且与其它无关肿瘤细胞的结合活性明显低于与SKOV3细胞的结合活性，说明它具有较好的靶向性及特异性。